Fundraising Fox

Avant Genomics

Charlottesville, US · Founded 2023 · 11 employees on LinkedIn · 5 known investors

Find your way into Avant Genomics

Avant Genomics is developing an automated platform for liquid biopsy sample preparation, using an enclosed fluidic cartridge and benchtop instruments that integrate DNA enrichment and purification for blood-based cancer detection. The system targets research labs, clinical testing environments, and reference laboratories aiming to reduce manual labor and cost in precision oncology workflows.

BiotechHealthtechMedical Devices

Founders & leadership

Avant Genomics was founded in 2023 by Rachelle and Renna.

RRachelle
RachelleinRachelle holds expertise in bioanalytical microfluidics and analytical chemistry, with background in developing integrated genetic systems for clinical diagnostics and forensic identification. As co-founder and CEO of Avant Genomics, she leads development of microfluidic technologies for blood-based cancer detection.
RRenna
RennainRenna Nouwairi holds a Ph.D. in bioanalytical chemistry and developed the core liquid biopsy technology during her doctoral and postdoctoral research at the University of Virginia. She is co-founder and COO of Avant Genomics, where she oversees operations, strategy, and cross-functional execution in microfluidics and analytical workflows for blood-based cancer detection.

Investors · 5

TitletownTech✓ verifiedGreen Bay · $100K – $2M
Virginia Venture Partners✓ verifiedRichmond · $100K

Also in the syndicate · 3

CAV AngelsGlobal Impact FundHalyard Ventures

Funding

SEC filings, press & company announcements

$3M disclosed across 1 of 2 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Avant Genomics has raised $3,500,000.00 in new Funding - intelligence360intelligence360.news · Jun 2026Avant Genomics Secures $3M+ in Funding to Accelerate First-in-kind Automated Platform for Liquid Biopsy Sample Preparation - BioSpacebiospace.com · May 2026Avant Genomics Secures $3M+ to Fix Cancer Test Bottleneck - BriefGlance.combriefglance.com · May 2026Avant Genomics Raises $3M for Automated Liquid Biopsy Sample Preparation | Clinical Lab Productsclpmag.com · May 2026Avant Genomics Secures $3M+ in Funding to Accelerate First-in-kind Automated Platform for Liquid Biopsy Sample Preparationbusinesswire.com · May 2026Avant Genomics Raises $3M+ in Fundingfinsmes.com · May 2026

Frequently asked questions

What does Avant Genomics do?
Avant Genomics is developing an automated platform for liquid biopsy sample preparation, using an enclosed fluidic cartridge and benchtop instruments that integrate DNA enrichment and purification for blood-based cancer detection. The system targets research labs, clinical testing environments, and reference laboratories aiming to reduce manual labor and cost in precision oncology workflows.
Who founded Avant Genomics?
Avant Genomics was founded by Rachelle, Renna in 2023.
Who are Avant Genomics's investors?
Avant Genomics's investors include TitletownTech, Virginia Venture Partners.
How much funding has Avant Genomics raised?
Avant Genomics has disclosed $3M raised across 1 of its 2 known rounds.
Where is Avant Genomics headquartered?
Avant Genomics is headquartered in Charlottesville, US.